Favourable outcomes for high-risk diffuse large B-cell lymphoma (IPI 3–5) treated with front-line R-CODOX-M/R-IVAC chemotherapy: results of a phase 2 UK NCRI trial
Titel:
Favourable outcomes for high-risk diffuse large B-cell lymphoma (IPI 3–5) treated with front-line R-CODOX-M/R-IVAC chemotherapy: results of a phase 2 UK NCRI trial
Auteur:
McMillan, A.K. Phillips, E.H. Kirkwood, A.A. Barrans, S. Burton, C. Rule, S. Patmore, R. Pettengell, R. Ardeshna, K.M. Lawrie, A. Montoto, S. Paneesha, S. Clifton-Hadley, L. Linch, D.C.